(R)-Methyl oxirane-2-carboxylate

Catalog No.: 
ACMQRY240
CAS No.: 
111058-32-3
Molecular Formula: 
C4H6O3
Molecular Weight: 
102.09
(R)-Methyl oxirane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$61.00In stockInquiry
10g98%$119.00In stockInquiry
25g98%$289.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-Methyl oxirane-2-carboxylate
IUPAC Namemethyl (R)-oxirane-2-carboxylate
MDL No.MFCD00274191
Molecular FormulaC4H6O3
Molecular Weight102.09
SMILESO=C([C@@H]1OC1)OC
InChI KeyYKNYRRVISWJDSR-GSVOUGTGSA-N
SynonymAS-15863 | (R)-Methyglycidate | MFCD00274191 | 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)- | BCP16542 | methyl(2R)-oxiran-2-carboxylate
CAS No.111058-32-3
PubChem CID9877347

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H225-H315-H319
Precautionary Statement(s)
P210-P233-P240-P241+P242+P243-P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313-P403+P235-P501

Synthetic Route by SureRoute

1. ACMQRY240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOWXT695 route compound structure diagram
    ACOWXT6957691-28-3In Stock
  2. Then
  3. ACMQRY240 route product structure diagram
    ACMQRY240111058-32-3In Stock
Inquiry

2. ACMQRY240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMQRY240 route product structure diagram
    ACMQRY240111058-32-3In Stock
Inquiry

3. ACMQRY240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMQRY240 route product structure diagram
    ACMQRY240111058-32-3In Stock
Inquiry

Comments (0)